No accessibility information available.
Book Details
The Organic Chemistry of Drug Design and Drug Action, Fourth Edition presents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action. The book's coverage allows readers to extrapolate core principles and mechanisms to many related classes of drug molecules. It reflects the significant changes in the process of drug design over the last decade and preserves the successful approach of the previous editions while also including significant changes in format and coverage.
It is designed for undergraduate and graduate students in chemistry who are studying medicinal chemistry or pharmaceutical chemistry. Users, including research chemists and biochemists working in pharmaceutical and biotechnology industries will find this update to be useful in their daily work.
Key Features
- Presents new figures that have been extensively updated and refreshed throughout, now in full color
- Provides case studies and up-to-date examples to make the book engaging for today’s student
- Includes new PowerPoint slides with clicker questions and a test bank to enhance the teaching experience
About the author
By Richard B. Silverman, Ph.D Organic Chemistry, Northwestern University, Evanston, IL, USA; Jose I Juncosa, Associate Professor Department of Chemistry Salisbury University, Salisbury, M, USA and Fengtian Xue, Associate Professor of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA2. Lead discovery
3. Lead modification
4. Receptors
5. Agonists and antagonists of receptors
6. Enzymes
7. Enzyme inhibition
8. DNA and RNA
9. DNA- and RNA-interactive agents
10. Other drug targets
11. Pharmacokinetics
12. Drug resistance and drug synergism
13. Prodrugs and delivery systems
9780198749691; 9781496385024; 9781498702782
Undergraduate and graduate students in chemistry studying medicinal chemistry or pharmaceutical chemistry, Research chemists and biochemists working in pharmaceutical and biotechnology industries